Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2002 2
2003 4
2006 1
2007 2
2008 2
2010 1
2012 2
2013 1
2014 3
2015 1
2016 6
2017 6
2018 7
2019 8
2020 11
2021 10
2022 8
2023 4
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
Collet JP, Van Belle E, Thiele H, Berti S, Lhermusier T, Manigold T, Neumann FJ, Gilard M, Attias D, Beygui F, Cequier A, Alfonso F, Aubry P, Baronnet F, Ederhy S, Kasty ME, Kerneis M, Barthelemy O, Lefèvre T, Leprince P, Redheuil A, Henry P, Portal JJ, Vicaut E, Montalescot G; ATLANTIS Investigators of the ACTION Group. Collet JP, et al. Among authors: manigold t. Eur Heart J. 2022 Aug 1;43(29):2783-2797. doi: 10.1093/eurheartj/ehac242. Eur Heart J. 2022. PMID: 35583186 Clinical Trial.
BRIGHT-4 trial: bivalirudin strikes back.
Piriou PG, Manigold T, Letocart V, Guérin P, Vourc'h M. Piriou PG, et al. Among authors: manigold t. Lancet. 2023 Apr 8;401(10383):1157-1158. doi: 10.1016/S0140-6736(23)00280-5. Lancet. 2023. PMID: 37030888 No abstract available.
[Multiprofessional treatment approach in chronic back pain].
Manigold T, Gantschnig BE, Streitberger K. Manigold T, et al. Z Rheumatol. 2023 Feb;82(1):31-37. doi: 10.1007/s00393-022-01258-6. Epub 2022 Sep 2. Z Rheumatol. 2023. PMID: 36053333 Free PMC article. Review. German.
Letter by Le Ruz and Manigold Regarding Article, "Compared Outcomes ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER MI Trial".
Le Ruz R, Manigold T. Le Ruz R, et al. Among authors: manigold t. Circ Cardiovasc Interv. 2022 Jan;15(1):e011587. doi: 10.1161/CIRCINTERVENTIONS.121.011587. Epub 2022 Jan 18. Circ Cardiovasc Interv. 2022. PMID: 35041456 No abstract available.
Gammopathy at first sight.
Manigold T, Loetscher J. Manigold T, et al. Rheumatology (Oxford). 2016 Sep;55(9):1641. doi: 10.1093/rheumatology/kew217. Epub 2016 May 30. Rheumatology (Oxford). 2016. PMID: 27241703 No abstract available.
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators. Silvain J, et al. Lancet. 2020 Nov 28;396(10264):1737-1744. doi: 10.1016/S0140-6736(20)32236-4. Epub 2020 Nov 14. Lancet. 2020. PMID: 33202219 Free article. Clinical Trial.
78 results